GAMMA Investing’s Abeona Therapeutics ABEO Stock Holding History

GAMMA Investing’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.6K	Buy	2,012 +261	+15%	+$1.62K	﹤0.01%	3303
2026 Q2	$10.8K	Buy	1,751 +842	+93%	+$4.62K	﹤0.01%	3165
2026 Q1	$4.07K	Buy	909 +819	+910%	+$4.09K	﹤0.01%	3439
2025 Q4	$474	Buy	90 +42	+88%	+$211	﹤0.01%	3921
2025 Q3	$253	Buy	+48	New	+$304	﹤0.01%	3788

Other funds holding ABEO

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ABEO Position: Q3 2026 in Review

GAMMA Investing increased its Abeona Therapeutics (ABEO) stake by 15% in Q3 2026, buying an estimated $1.62K and bringing the position to 2,012 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3303.

GAMMA Investing first reported a position in ABEO in Q3 2025 and has held it in 5 quarters since. The position peaked at $10.8K in Q2 2026. 2 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

GAMMA Investing held 2,012 shares of Abeona Therapeutics worth $10.6K as of Q3 2026.
GAMMA Investing bought 261 Abeona Therapeutics shares in Q3 2026, an estimated $1.62K.
Abeona Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3303 holding.
GAMMA Investing first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 5 quarters since.
GAMMA Investing's Abeona Therapeutics position peaked at $10.8K in Q2 2026.
2 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.